{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:14:34Z","timestamp":1772748874319,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.leukres.2006.07.016","type":"journal-article","created":{"date-parts":[[2006,9,19]],"date-time":"2006-09-19T15:16:16Z","timestamp":1158678976000},"page":"445-454","source":"Crossref","is-referenced-by-count":33,"title":["Contrasting features of MDR phenotype in leukemias by using two fluorochromes: Implications for clinical practice"],"prefix":"10.1016","volume":"31","author":[{"given":"Flavia C.","family":"Vasconcelos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Geraldo B.","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina L.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"de Meis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolie K.","family":"Kwee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian M.","family":"Rumjanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel C.","family":"Maia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2006.07.016_bib1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu Ver Med"},{"key":"10.1016\/j.leukres.2006.07.016_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1182\/blood.V96.1.365","article-title":"Expression of breast cancer resistance protein in blast cells from patients with acute leukaemia","volume":"96","author":"Ross","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.07.016_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00001622-199511000-00012","article-title":"Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance","volume":"7","author":"Reed","year":"1995","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.leukres.2006.07.016_bib4","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.1038\/sj.onc.1207101","article-title":"The inhibitors of apoptosis: there is more to life than Bcl2","volume":"22","author":"Liston","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2006.07.016_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.pharmtox.45.120403.095857","article-title":"Glutathione Transferases","volume":"45","author":"Hayes","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.leukres.2006.07.016_bib6","first-page":"3010","article-title":"Methods to detect P-glycoprotein-associated multidrug resistance in patient's tumors: consensus recommendation","volume":"56","author":"Beck","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2006.07.016_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/14737159.4.2.209","article-title":"Progress in defining multidrug resistance in leukemia","volume":"4","author":"Kappelmayer","year":"2004","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.leukres.2006.07.016_bib8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1432-1033.2003.03403.x","article-title":"New insights into the P-glycoprotein-mediated effluxes of rhodamines","volume":"270","author":"Loetchutinat","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.leukres.2006.07.016_bib9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/bjc.1995.371","article-title":"Functional detection of MDR P170 and MRP\/P190-mediated multidrug resistance in tumour cells by flow cytometry","volume":"72","author":"Feller","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.leukres.2006.07.016_bib10","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1182\/blood.V87.11.4809.bloodjournal87114809","article-title":"Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity","volume":"87","author":"Broxterman","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.07.016_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/B:BIRE.0000007693.33521.18","article-title":"Mitotracker green is a P-glycoprotein substrate","volume":"23","author":"Marques-Santos","year":"2003","journal-title":"Biosci Rep"},{"key":"10.1016\/j.leukres.2006.07.016_bib12","first-page":"145","article-title":"Overexpression of the ATP-binding cassette half-transporter ABCG2 (MXR\/BCRP\/ABCP1), in flavopiridol-resistant human breast cancer cells","volume":"7","author":"Robey","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2006.07.016_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/02841869509093961","article-title":"Comparative study on reversal efficacy of SDZ PSC 833 Cyclosporin A and Verapamil on multidrug resistance \u201cin vitro\u201d and \u201cin vivo\u201d","volume":"34","author":"Watanabe","year":"1995","journal-title":"Acta Oncol"},{"key":"10.1016\/j.leukres.2006.07.016_bib14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s002800050640","article-title":"Probenecide reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60\/AR and H69\/AR cells but not in P-glycoprotein-overexpressing HL-60Tax and P388\/ADR cells","volume":"40","author":"Gollapudi","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.leukres.2006.07.016_bib15","first-page":"47","article-title":"Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein","volume":"60","author":"Rabindran","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2006.07.016_bib16","first-page":"63","article-title":"Multidrug resistance in leukemias: the problem and some approaches to its circumvention","volume":"46","author":"Rumjanek","year":"1994","journal-title":"Cienc Cult"},{"key":"10.1016\/j.leukres.2006.07.016_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1590\/S0001-37652001000100007","article-title":"Multidrug resistance in tumour cells: characterisation of the multidrug resistant cell line K562-Lucena 1","volume":"73","author":"Rumjanek","year":"2001","journal-title":"Ann Acad Bras Ci"},{"key":"10.1016\/j.leukres.2006.07.016_bib18","first-page":"751","article-title":"Establishment and properties of a vincristine-resistant human myelogenous leukemia K562","volume":"74","author":"Tsuruo","year":"1983","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.leukres.2006.07.016_bib19","first-page":"467","article-title":"Sensitivity of vincristine-sensitive K562 and vincristine K562-Lucena 1 cells to anthracyclines and reversal of multidrug resistance","volume":"29","author":"Maia","year":"1996","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.leukres.2006.07.016_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000029973","article-title":"Comparison between anthracyclines and rhodamine-123 accumulation in chronic lymphoid leukemia: effect of cyclosporin A and verapamil","volume":"19","author":"Maia","year":"1998","journal-title":"Tumour Biol"},{"key":"10.1016\/j.leukres.2006.07.016_bib21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ijc.2910600518","article-title":"Mechanisms of MRP over-expression in four human lung-cancer cell lines and analysis of the MRP amplicon","volume":"60","author":"Eijdems","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.leukres.2006.07.016_bib22","first-page":"310","article-title":"Monoclonal antibody to an external epitope of the human mdr1 p-glycoprotein","volume":"15","author":"Arceci","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2006.07.016_bib23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0145-2126(02)00094-2","article-title":"CPT-11 induced cell death in leukemic cells is not affected by the MDR phenotype","volume":"27","author":"Silva","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2006.07.016_bib24","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/jcp.47.9.843","article-title":"Demonstration of cytoplasmic and nuclear antigens in acute leukaemia using flow cytometry","volume":"47","author":"Farahat","year":"1994","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.leukres.2006.07.016_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.20013","article-title":"Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia","volume":"61B","author":"Cavalcanti","year":"2004","journal-title":"Cytometry"},{"key":"10.1016\/j.leukres.2006.07.016_bib26","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/0959-8049(94)90187-2","article-title":"A comparison of rhodamine-123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multi-drug resistance phenotypes","volume":"30","author":"Twentyman","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.leukres.2006.07.016_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1097-0320(19960901)25:1<14::AID-CYTO2>3.0.CO;2-E","article-title":"DiOC2 (3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux","volume":"25","author":"Minderman","year":"1996","journal-title":"Cytometry"},{"key":"10.1016\/j.leukres.2006.07.016_bib28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/(SICI)1097-0320(19981215)34:6<248::AID-CYTO2>3.0.CO;2-X","article-title":"Reference method for detection of Pgp mediated multi-drug resistance in human hematological malignancies: a method validated by the laboratories of the French Drug Resistance Network","volume":"34","author":"Huet","year":"1998","journal-title":"Cytometry"},{"key":"10.1016\/j.leukres.2006.07.016_bib29","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1182\/blood.V93.12.4086","article-title":"Altered multi-drug resistence phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia","volume":"93","author":"Hu","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.07.016_bib30","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1182\/blood.V86.6.2329.bloodjournal8662329","article-title":"Correlation of multidrug resistance (MDR1) protein expression with functional dye\/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR1\u2212\/efflux+ and MDR1+\/efflux\u2212 cases","volume":"86","author":"Leith","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.07.016_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4615-4811-9_13","article-title":"Discordance of P-glycoprotein expression and function in acute leukemia","volume":"457","author":"De Moerloose","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.leukres.2006.07.016_bib32","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/(SICI)1097-0142(19990901)86:5<805::AID-CNCR16>3.0.CO;2-E","article-title":"Multidrug resistance protein expression in chronic myeloid leukemia","volume":"86","author":"Giles","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2006.07.016_bib33","first-page":"200","article-title":"Overexpression of MDR-related p170 glycoprotein in chronic myeloid leukemia","volume":"79","author":"Michelutti","year":"1994","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2006.07.016_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.leukres.2003.09.002","article-title":"Evaluation Of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients","volume":"28","author":"Galimberti","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2006.07.016_bib35","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/10428190290016773","article-title":"The role of drug efflux pumps in acute myeloid leukemia","volume":"43","author":"Van der Kolk","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2006.07.016_bib36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/10428190500032612","article-title":"The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology Group","volume":"46","author":"Olson","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2006.07.016_bib37","first-page":"1201","article-title":"P-glycoprotein 170 expression and function as an adverse independent prognostic factor in childhood acute lymphoblastic leukemia","volume":"12","author":"Casale","year":"2004","journal-title":"Oncol Rep"},{"key":"10.1016\/j.leukres.2006.07.016_bib38","first-page":"1261","article-title":"The relevance of multidrug resistance-associated P-glycoprotein expression in the treatment response of B-cell chronic lymphocytic leukemia","volume":"85","author":"Svoboda-Beusan","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2006.07.016_bib39","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1182\/blood-2001-12-0371","article-title":"MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia","volume":"100","author":"Tafuri","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.07.016_bib40","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.leukres.2003.10.015","article-title":"Evaluation and comparison of MRP1 activity with threee fluorescent dyes and three modulators in leukemic cell lines","volume":"28","author":"Dogan","year":"2004","journal-title":"Leukemia Res"},{"key":"10.1016\/j.leukres.2006.07.016_bib41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/1389557053402693","article-title":"Inhibitors of multidrug efflux transporters: their membrane and protein interactions","volume":"5","author":"Seelig","year":"2005","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.leukres.2006.07.016_bib42","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1124\/mol.65.4.897","article-title":"Glutathione S-transferase M1 and multidrug resistance protein 1 act in synergy to protect melanoma cells from vincristine effects","volume":"65","author":"Depeille","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.leukres.2006.07.016_bib43","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.leu.2403257","article-title":"P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate","volume":"18","author":"Ilmer","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2006.07.016_bib44","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1182\/blood-2004-04-1398","article-title":"Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP\/ABCG2) drug pump","author":"Burger","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.07.016_bib45","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1248\/bpb.21.1062","article-title":"Inhibition of vimblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells","volume":"21","author":"Takanaga","year":"1998","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.leukres.2006.07.016_bib46","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1211\/002235702320402053","article-title":"Inhibitory effect of fruit extracts on P-glycoprotein-related efflux carriers; an in-vitro screening","volume":"54","author":"Deferne","year":"2002","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.leukres.2006.07.016_bib47","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/0959-8049(96)00045-7","article-title":"How to probe clinical tumor samples for P-glycoprotein and multidrug resistance-associated protein","volume":"32A","author":"Broxterman","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.leukres.2006.07.016_bib48","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1182\/blood-2004-08-3303","article-title":"Reproducible measurements of AML blast P-glycoprotein function in 2 center analyses","volume":"105","author":"Pallis","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.07.016_bib49","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1021\/jm021099i","article-title":"Modulation of P-glycoprotein-mediated multidrug resistant by flavonoid derivatives and analogues","volume":"46","author":"Hadjeri","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.leukres.2006.07.016_bib50","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1158\/1078-0432.CCR-04-1725","article-title":"Cyclosporin A is a broad-spectrum multidrug resistance modulator","volume":"11","author":"Qadir","year":"2005","journal-title":"Clin Cancer Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212606002773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212606002773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T08:15:55Z","timestamp":1587197755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212606002773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0145212606002773"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2006.07.016","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}